Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Zero Based Budgeting focuses your budget on current goals, ensuring every dollar supports progress. Learn how to redefine priorities and monitor progress toward new targets.
26,970 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
SpaceX's IPO is on the horizon, but you can gain exposure today through a strategic backdoor. This article explains w...
A tax-efficient strategy called a free muni bond portfolio could yield about $75,000 in federal tax-free income from ...
A new survey shows a growing openness among high earners to expatriate, signaling shifting expectations for the U.S. ...
As market dynamics shift in 2026, investors weigh broad market exposure against a tech-heavy Nasdaq-100 tilt. This re...
Tired of slow growth from buying one rental at a time? Discover how a portfolio approach can accelerate scale, maximi...
A high-income professional taps a tax-smart 401(k) path—after-tax contributions plus in-plan Roth conversions—to turn...
As tax policy and market conditions evolve, a single variable—current versus retirement tax rate—drives whether tradi...
CFO compensation rose about 8% in 2025 as long-term incentives surged last year—and long-term incentives now dominate...
Savers chasing steady monthly income must quantify capital needs across three risk levels. A July 2026 snapshot shows...
Federal Reserve staff are more worried about stock prices than tech debt as AI-driven spending drives bond issuance a...
A new Goldman Sachs retirement survey projects retirement costs could climb to about $2.57 million by 2043, underscor...